Recent progress of tumor infiltrating lymphocyte therapy for advanced cervical cancer

VernacularTitle:晚期子宫颈癌肿瘤浸润淋巴细胞疗法的最新研究进展
Author: Ni GAO ¹ ; Linqing YANG ; Jing XU
Author Information

1. 济宁医学院临床医学院，济宁　272000
Keywords: Uterine cervical neoplasms; Immunotherapy; Lymphocytes, tumor-infiltrating; Prognosis
From: Cancer Research and Clinic 2023;35(12):950-953
CountryChina
Language:Chinese
Abstract: Tumor infiltrating lymphocyte (TIL) therapy is an emerging immunotherapy for the treatment of solid tumors in recent years, with strong specificity and targeting. Cervical cancer is a solid tumor suitable for immunotherapy with strong immunogenicity, and current studies suggest that TIL therapy can bring a new breakthrough in the treatment of advanced cervical cancer. This article reviews the recent progress of TIL therapy for advanced cervical cancer.